Table 1. Baseline Characteristicsa.
| Conventional troponin assay, No. (%) | P valueb | hs-cTnI Assay, No. (%) | P valueb | |||
|---|---|---|---|---|---|---|
| Transgender women (n = 521) | Transgender men (n = 325) | Transgender women (n = 140) | Transgender men (n = 122) | |||
| Age, median (IQR), y | 40 (28-54) | 28 (22-37) | <.001 | 33 (24-48) | 31 (25-39) | .007 |
| Race and ethnicityc | ||||||
| Asian | 46 (8.8) | 11 (3.4) | .003 | 13 (9.3) | 7 (5.7) | <.001 |
| Black | 43 (8.3) | 46 (14.1) | 6 (4.3) | 13 (10.7) | ||
| Hispanic | 159 (30.5) | 104 (32.0) | 38 (27.1) | 59 (48.4) | ||
| White | 256 (49.1) | 152 (46.8) | 79 (56.4) | 37 (30.3) | ||
| Other | 17 (3.3) | 12 (3.7) | 4 (2.9) | 6 (4.9) | ||
| Insurance | ||||||
| Commercial | 311 (59.7) | 212 (65.2) | .001 | 84 (60.0) | 81 (66.4) | .05 |
| Medicare | 66 (12.7) | 15 (4.6) | 14 (10.0) | 3 (2.4) | ||
| Medicaid | 60 (11.5) | 40 (12.3) | 23 (16.4) | 16 (13.1) | ||
| Otherd | 84 (16.1) | 58 (17.8) | 19 (13.6) | 22 (18.0) | ||
| Comorbidities | ||||||
| Hypertension | 121 (23.2) | 35 (10.8) | <.001 | 19 (13.6) | 14 (11.5) | .61 |
| Diabetes | 67 (12.9) | 23 (7.1) | .008 | 9 (6.4) | 9 (7.4) | .76 |
| Obesity | 112 (21.5) | 79 (24.3) | .34 | 20 (14.3) | 28 (22.9) | .07 |
| Heart failure | 5 (0.9) | 2 (0.6) | .59 | 1 (0.7) | 1 (0.8) | .92 |
| Coronary artery disease | 20 (3.8) | 0 | <.001 | 3 (2.1) | 1 (0.8) | .38 |
| Atrial fibrillation | 5 (0.9) | 2 (0.6) | .59 | 2 (1.4) | 1 (0.8) | .64 |
| Valvular heart disease | 5 (0.9) | 1 (0.3) | .27 | 5 (3.6) | 1 (0.8) | .14 |
| Kidney failure | 32 (6.1) | 6 (1.9) | .003 | 0 | 1 (0.8) | .28 |
| COPD or asthma | 83 (15.9) | 72 (22.2) | .02 | 30 (21.4) | 20 (16.4) | .30 |
| Liver disease | 28 (5.4) | 6 (1.9) | .01 | 7 (5.0) | 3 (2.5) | .28 |
| Depression | 174 (33.4) | 115 (35.4) | .55 | 75 (53.6) | 45 (36.9) | .007 |
Abbreviations: COPD, chronic obstructive pulmonary disease; hs-cTnI, high-sensitivity cardiac troponin I.
a
Unpaired, 2-tailed t test for continuous variables; χ2 test for categorical variables.
b
P values are given for transgender men vs transgender women.
c
Race and ethnicity were self-reported. Other race and ethnicity included undisclosed information, mixed race, and unknown.
d
Other insurance included self-insured or unknown.